Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessia Ligresti

Showing results (41-50 of 117) with videos related to

Pageof 12
Sort By:
Journal of Medicinal Chemistry|May 11, 2012
Indole-2-carboxamides as allosteric modulators of the cannabinoid CB₁ receptorFrancesco Piscitelli, Alessia Ligresti, Giuseppe La Regina, et al.
Bioorganic & Medicinal Chemistry Letters|April 22, 2008
New tetrazole-based selective anandamide uptake inhibitorsGiorgio Ortar, Aniello Schiano Moriello, Maria Grazia Cascio, et al.
British Journal of Pharmacology|December 24, 2010
Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymesLuciano De Petrocellis, Alessia Ligresti, Aniello Schiano Moriello, et al.
Biochemical Pharmacology|November 16, 2023
Dual allosteric and orthosteric pharmacology of synthetic analog cannabidiol-dimethylheptyl, but not cannabidiol, on the cannabinoid CB<sub>2</sub> receptorJara Bouma, Jeremy D Broekhuis, Cas van der Horst, et al.
Frontiers in Neuroscience|August 12, 2016
Synthesis and Biological Evaluation of Thiophene-Based Cannabinoid Receptor Type 2 Radiotracers for PET ImagingAchi Haider, Adrienne Müller Herde, Roger Slavik, et al.
European Journal of Medicinal Chemistry|July 25, 2016
Discovery of novel Tetrahydrobenzo[b]thiophene and pyrrole based scaffolds as potent and selective CB2 receptor ligands: The structural elements controlling binding affinity, selectivity and functionalityNoha A Osman, Alessia Ligresti, Christian D Klein, et al.
Molecules (Basel, Switzerland)|December 11, 2022
<i>N</i>-[1,3-Dialkyl(aryl)-2-oxoimidazolidin-4-ylidene]-aryl(alkyl)sulphonamides as Novel Selective Human Cannabinoid Type 2 Receptor (hCB2R) Ligands; Insights into the Mechanism of Receptor Activation/DeactivationEleonora Gianquinto, Federica Sodano, Barbara Rolando, et al.
Journal of Medicinal Chemistry|January 13, 2016
Investigations on the 4-Quinolone-3-carboxylic Acid Motif. 7. Synthesis and Pharmacological Evaluation of 4-Quinolone-3-carboxamides and 4-Hydroxy-2-quinolone-3-carboxamides as High Affinity Cannabinoid Receptor 2 (CB2R) Ligands with Improved Aqueous SolubilityClaudia Mugnaini, Antonella Brizzi, Alessia Ligresti, et al.
British Journal of Pharmacology|May 19, 2012
Non-THC cannabinoids inhibit prostate carcinoma growth in vitro and in vivo: pro-apoptotic effects and underlying mechanismsLuciano De Petrocellis, Alessia Ligresti, Aniello Schiano Moriello, et al.
Bioorganic & Medicinal Chemistry Letters|October 31, 2009
Synthesis and biological evaluation of piperazinyl carbamates and ureas as fatty acid amide hydrolase (FAAH) and transient receptor potential (TRP) channel dual ligandsEnrico Morera, Luciano De Petrocellis, Ludovica Morera, et al.
Pageof 12

Showing results (41-50 of 117) with videos related to

Sort By:
Pageof 12
Journal of Medicinal Chemistry|May 11, 2012
Indole-2-carboxamides as allosteric modulators of the cannabinoid CB₁ receptorFrancesco Piscitelli, Alessia Ligresti, Giuseppe La Regina, et al.
Bioorganic & Medicinal Chemistry Letters|April 22, 2008
New tetrazole-based selective anandamide uptake inhibitorsGiorgio Ortar, Aniello Schiano Moriello, Maria Grazia Cascio, et al.
British Journal of Pharmacology|December 24, 2010
Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymesLuciano De Petrocellis, Alessia Ligresti, Aniello Schiano Moriello, et al.
Biochemical Pharmacology|November 16, 2023
Dual allosteric and orthosteric pharmacology of synthetic analog cannabidiol-dimethylheptyl, but not cannabidiol, on the cannabinoid CB<sub>2</sub> receptorJara Bouma, Jeremy D Broekhuis, Cas van der Horst, et al.
Frontiers in Neuroscience|August 12, 2016
Synthesis and Biological Evaluation of Thiophene-Based Cannabinoid Receptor Type 2 Radiotracers for PET ImagingAchi Haider, Adrienne Müller Herde, Roger Slavik, et al.
European Journal of Medicinal Chemistry|July 25, 2016
Discovery of novel Tetrahydrobenzo[b]thiophene and pyrrole based scaffolds as potent and selective CB2 receptor ligands: The structural elements controlling binding affinity, selectivity and functionalityNoha A Osman, Alessia Ligresti, Christian D Klein, et al.
Molecules (Basel, Switzerland)|December 11, 2022
<i>N</i>-[1,3-Dialkyl(aryl)-2-oxoimidazolidin-4-ylidene]-aryl(alkyl)sulphonamides as Novel Selective Human Cannabinoid Type 2 Receptor (hCB2R) Ligands; Insights into the Mechanism of Receptor Activation/DeactivationEleonora Gianquinto, Federica Sodano, Barbara Rolando, et al.
Journal of Medicinal Chemistry|January 13, 2016
Investigations on the 4-Quinolone-3-carboxylic Acid Motif. 7. Synthesis and Pharmacological Evaluation of 4-Quinolone-3-carboxamides and 4-Hydroxy-2-quinolone-3-carboxamides as High Affinity Cannabinoid Receptor 2 (CB2R) Ligands with Improved Aqueous SolubilityClaudia Mugnaini, Antonella Brizzi, Alessia Ligresti, et al.
British Journal of Pharmacology|May 19, 2012
Non-THC cannabinoids inhibit prostate carcinoma growth in vitro and in vivo: pro-apoptotic effects and underlying mechanismsLuciano De Petrocellis, Alessia Ligresti, Aniello Schiano Moriello, et al.
Bioorganic & Medicinal Chemistry Letters|October 31, 2009
Synthesis and biological evaluation of piperazinyl carbamates and ureas as fatty acid amide hydrolase (FAAH) and transient receptor potential (TRP) channel dual ligandsEnrico Morera, Luciano De Petrocellis, Ludovica Morera, et al.
Pageof 12